Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Type 2 Diabetes With Acute Myocardial Infarction
NCT05050500Phase 4Completed
- Sponsor
- Affiliated Qingdao Central Hospital of Qingdao University
- Start
- May 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in acute myocardial infarction (AMI), sponsored by Affiliated Qingdao Central Hospital of Qingdao University. Started May 2023; status: completed.
02
Drugs
dapagliflozin
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT05050500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05050500.